Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $77 | $0 | $65 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $47 | $0 | $49 |
| Inventory | $0 | $62 | $0 | $62 |
| Other Curr. Assets | $0 | $32 | $0 | $30 |
| Total Curr. Assets | $1 | $218 | $1 | $205 |
| Property Plant & Equip (Net) | $1 | $90 | $1 | $89 |
| Goodwill | $0 | $47 | $0 | $50 |
| Intangibles | $0 | $9 | $0 | $8 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $4 | $0 | $0 |
| Other NC Assets | $0 | $53 | $0 | $57 |
| Total NC Assets | $1 | $204 | $1 | $203 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3 | $422 | $3 | $408 |
| Liabilities | – | – | – | – |
| Payables | $0 | $19 | $0 | $20 |
| Short-Term Debt | $0 | $7 | $0 | $24 |
| Tax Payable | $0 | $7 | $0 | $6 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $62 | $0 | $61 |
| Total Curr. Liab. | $1 | $95 | $1 | $111 |
| LT Debt | $0 | $43 | $0 | $20 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2 | $0 | $0 |
| Other NC Liab. | $0 | $11 | $0 | $13 |
| Total NC Liab. | $0 | $56 | $0 | $33 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1 | $150 | $1 | $144 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $7 | $0 | $7 |
| Retained Earnings | $2 | $228 | $1 | $214 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $35 | $0 | $37 |
| Total Equity | $2 | $260 | $2 | $253 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $11 | $0 | $11 |
| Total Liab. & Tot. Equity | $3 | $422 | $3 | $408 |
| Net Debt | -$0 | -$27 | -$0 | -$20 |